Use of Ceftazidime-Avibactam and Ceftolozane-Tazobactam After Lung Transplantation

被引:0
|
作者
Amore, Davide [1 ]
Pecoraro, Ylenia [1 ]
Carillo, Carolina [1 ]
Russo, Gianluca [4 ]
Poggi, Camilla [1 ]
Anile, Marco [1 ]
Pagini, Andreina [1 ]
Bassi, Massimiliano [1 ]
Cagnetti, Sara [1 ]
Mottola, Emilia [1 ]
D'Agostino, Federica Gilda [1 ]
Vannucci, Jacopo [1 ]
Mantovani, Sara [1 ]
Pugliese, Francesco [2 ]
De Giacomo, Tiziano [1 ]
Rendina, Erino Angelo [3 ]
Venuta, Federico [4 ]
Diso, Daniele [1 ]
机构
[1] Sapienza Univ Rome, AOU Policlin Umberto I, Div Thorac Surg & Lung Transplant, Viale Policlin 155, I-00161 Rome, Italy
[2] Sapienza Univ Rome, AOU Policlin Umberto I, Div Anesthesiol & Intens Care, Unit Organs Transplant, Rome, Italy
[3] Sapienza Univ Rome, AOU St Andrea, Div Thorac Surg, Rome, Italy
[4] Sapienza Univ Rome, AOU Policlin Umberto I, Div Infect Dis, Rome, Italy
关键词
CYSTIC-FIBROSIS; INFECTIONS; PNEUMONIA;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1605 / 1607
页数:3
相关论文
共 50 条
  • [1] Monotherapy of ceftazidime-avibactam and ceftolozane-tazobactam against multidrug-resistant organisms
    Alatoom, Adnan
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 62 : 126 - 126
  • [2] Newer Intravenous Antibiotics in the Intensive Care Unit: Ceftaroline, Ceftolozane-Tazobactam, and Ceftazidime-Avibactam
    Connor, Kathryn A.
    AACN ADVANCED CRITICAL CARE, 2016, 27 (04) : 353 - 357
  • [3] Ceftazidime-avibactam and ceftolozane-tazobactam susceptibility of multidrug resistant Pseudomonas aeruginosa strains in Hungary
    O'Neall, Dustin
    Juhasz, Emese
    Toth, Akos
    Urban, Edit
    Szabo, Judit
    Melegh, Szilvia
    Katona, Katalin
    Kristof, Katalin
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2020, 67 (01) : 61 - 65
  • [4] Evaluation of the In vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Ceftazidime-Resistant Pseudomonas aeruginosa Isolates
    Bilgin, Melek
    Basbulut, Ese
    Isler, Hacer
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2021, 26 (04): : 713 - 719
  • [5] Persistent bacteremia from Pseudomonas aeruginosa resistant to the novel antibiotics ceftolozane-tazobactam and ceftazidime-avibactam
    Gangcuangco, L. M.
    Clark, P.
    Stewart, C.
    Miljkovic, G.
    Saul, Z.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 : 301 - 301
  • [6] Activity of Ceftolozane-Tazobactam and Ceftazidime-Avibactam against Beta-Lactam-Resistant Pseudomonas aeruginosa Isolates
    Humphries, Romney M.
    Hindler, Janet A.
    Wong-Beringer, Annie
    Miller, Shelley A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (12)
  • [7] CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CEFTOLOZANE- TAZOBACTAM AND CEFTAZIDIME-AVIBACTAM
    Beatty, Julia
    Liao, Siyun
    Droege, Chris
    CRITICAL CARE MEDICINE, 2020, 48
  • [8] Clinical outcomes and emergence of resistance of Pseudomonas aeruginosa infections treated with ceftolozane-tazobactam versus ceftazidime-avibactam
    Hareza, Dariusz A.
    Cosgrove, Sara E.
    Bonomo, Robert A.
    Dzintars, Kathryn
    Karaba, Sara M.
    Hawes, Armani M.
    Tekle, Tsigereda
    Simner, Patricia J.
    Tamma, Pranita D.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024,
  • [9] Persistent Bacteremia from Pseudomonas aeruginosa with In Vitro Resistance to the Novel Antibiotics Ceftolozane-Tazobactam and Ceftazidime-Avibactam
    Gangcuangco, Louie Mar
    Clark, Patricia
    Stewart, Cynthia
    Miljkovic, Goran
    Saul, Zane K.
    CASE REPORTS IN INFECTIOUS DISEASES, 2016, 2016
  • [10] In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis
    Nolan, Patrick J.
    Jain, Raksha
    Cohen, Leah
    Finklea, James D.
    Smith, Tiffeny T.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2021, 99 (02)